ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis

Ying Guo, Yuan Zhou, Shohei Yamatomo, Hui Yang, Peng Zhang, Shi Chen, Stephen D Nimer, Zhizhuang Joe Zhao, Mingjiang Xu, Jie Bai, Feng-Chun Yang

Research output: Contribution to journalArticle

4 Scopus citations
Original languageEnglish (US)
JournalLeukemia
DOIs
StateAccepted/In press - Jan 1 2019

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Guo, Y., Zhou, Y., Yamatomo, S., Yang, H., Zhang, P., Chen, S., Nimer, S. D., Zhao, Z. J., Xu, M., Bai, J., & Yang, F-C. (Accepted/In press). ASXL1 alteration cooperates with JAK2V617F to accelerate myelofibrosis. Leukemia. https://doi.org/10.1038/s41375-018-0347-y